CLDN8 and cancer: Similarly, Claudin 8 (CLDN8), a tight junction protein dysregulated in a number of cancers [40], is down-regulated in ductal carcinomas compared to the normal breast (Figure 7) and is associated with differential survival of patients with ER+/PR+ vs. ER−/PR− disease.